Asif Ali

Insider Reports History

Location
Newark, CA
Signature
/s/ Matthew Gosling, Attorney-in-Fact for Asif Ali
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Asif Ali:

Company Role Class Num Shares Value Price $ Report Date Ownership
Protagonist Therapeutics, Inc Chief Financial Officer Common Stock 86,665 $7,569,303 $87.34 02 Jan 2026 Direct
Protagonist Therapeutics, Inc Chief Financial Officer Stock Option (right to buy) 32,000 02 Jan 2026 Direct

Insider Reports Filed by Asif Ali

Symbol Company Period Transactions Value $ Form Type Role Filing Time
PTGX Protagonist Therapeutics, Inc 02 Jan 2026 2 $0 4 Chief Financial Officer 06 Jan 2026, 19:37
PTGX Protagonist Therapeutics, Inc 22 Apr 2025 1 -$80,776 4 Chief Financial Officer 23 Apr 2025, 16:30
PTGX Protagonist Therapeutics, Inc 12 Mar 2025 5 -$1,091,390 4 Chief Financial Officer 14 Mar 2025, 18:20
PTGX Protagonist Therapeutics, Inc 16 Jan 2025 2 $0 4 Chief Financial Officer 17 Jan 2025, 17:45
PTGX Protagonist Therapeutics, Inc 02 Jan 2025 2 $0 4 Chief Financial Officer 06 Jan 2025, 18:05
PTGX Protagonist Therapeutics, Inc 11 Sep 2024 6 -$443,712 4 Chief Financial Officer 13 Sep 2024, 16:35
PTGX Protagonist Therapeutics, Inc 18 Apr 2024 1 -$30,986 4 Chief Financial Officer 19 Apr 2024, 20:05
PTGX Protagonist Therapeutics, Inc 29 Feb 2024 6 -$618,325 4 Chief Financial Officer 01 Mar 2024, 20:45
PTGX Protagonist Therapeutics, Inc 16 Jan 2024 1 -$35,763 4 Chief Financial Officer 18 Jan 2024, 20:00
PTGX Protagonist Therapeutics, Inc 02 Jan 2024 2 $0 4 Chief Financial Officer 04 Jan 2024, 20:07
PTGX Protagonist Therapeutics, Inc 31 May 2023 2 -$108,190 4 Chief Financial Officer 02 Jun 2023, 19:48
PTGX Protagonist Therapeutics, Inc 18 Apr 2023 1 -$27,597 4 Chief Financial Officer 19 Apr 2023, 16:28
PTGX Protagonist Therapeutics, Inc 16 Jan 2023 2 $0 4 Chief Financial Officer 18 Jan 2023, 18:53
PTGX Protagonist Therapeutics, Inc 18 Apr 2022 2 $0 4 Chief Financial Officer 19 Apr 2022, 19:48
PTGX Protagonist Therapeutics, Inc 18 Apr 2022 0 $0 3 Chief Financial Officer 19 Apr 2022, 19:35